专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110130849A1 SENSOR ACTUATOR NODE AND METHOD FOR HANDLING CIRCUMSTANTIAL CHANGES IN SENSOR ACTUATOR NETWORK USING SAME 审中-公开
标题翻译：传感器执行器节点和方法，用于处理传感器执行器网络中的电路变化
公开(公告)号：US20110130849A1
公开(公告)日：2011-06-02
申请号：US12857101
申请日：2010-08-16
申请人： Sun-Jin Kim , Junghae Seo , Kwang Soo Kim , Cheol Sig Pyo , Jong-Arm Jun , Jong-Suk Chae
发明人： Sun-Jin Kim , Junghae Seo , Kwang Soo Kim , Cheol Sig Pyo , Jong-Arm Jun , Jong-Suk Chae
IPC分类号： G05B11/01
CPC分类号： G08B25/08
摘要： A sensor actuator node includes a sensor unit for generating sensing information on circumstantial changes; a communications unit; a countermeasure information generation unit for generating countermeasure information to the circumstantial changes; and a drive unit for driving one or more actuators. When the sensor actuator node acts as a host node, the sensing information becomes main sensing information, the countermeasure information generation unit generates the countermeasure information based on the main sensing information and selectively transmits the countermeasure information to the adjacent sensor actuator nodes via the communications unit, and the drive unit drives the actuator based on the countermeasure information. When the sensor actuator node acts as a non-host node, the sensing information becomes auxiliary sensing information, and the drive unit drives the actuator based on the countermeasure information selectively transmitted thereto by the host node.
摘要翻译：传感器致动器节点包括用于产生关于环境变化的感测信息的传感器单元; 通信单元; 对策信息生成单元，用于产生对环境变化的对策信息; 以及用于驱动一个或多个致动器的驱动单元。当传感器致动器节点作为主机节点时，感测信息变为主感测信息，对策信息生成单元基于主感测信息产生对策信息，并且经由通信单元选择性地将对策信息发送到相邻的传感器致动器节点，并且驱动单元基于对策信息驱动致动器。当传感器致动器节点用作非主机节点时，感测信息成为辅助感测信息，并且驱动单元基于由主机节点有选择地发送到其的对策信息来驱动致动器。

2. 发明授权

US07928840B2 Method and system for preventing loss or theft using wireless PAN or LAN 有权
标题翻译：使用无线PAN或LAN防止丢失或盗窃的方法和系统
公开(公告)号：US07928840B2
公开(公告)日：2011-04-19
申请号：US12062120
申请日：2008-04-03
申请人： Sun-Jin Kim , Junghae Seo , Sun-Joong Kim , Cheol Sig Pyo , Jong-Suk Chae
发明人： Sun-Jin Kim , Junghae Seo , Sun-Joong Kim , Cheol Sig Pyo , Jong-Suk Chae
IPC分类号： G08B1/00
CPC分类号： G08B13/1436 , G08B13/1427 , G08B13/1472 , G08B21/0238 , G08B21/0261 , G08B21/0277
摘要： A method and system of preventing a loss/theft of a surveillance target including a mobile device using a wireless personal area network (PAN) or a wireless local area network (LAN) which can receive, from the mobile device included in the surveillance target via a gateway, location information of the surveillance target generated by using mobile device information for the surveillance target, the mobile device information being collected by a sensor of the mobile device, and signal information communicated between the mobile device and a fixed device, can determine whether there is a loss or theft by comparing surveillance target information and a permission standard, and can provide alert information including the location information of the surveillance target when the loss or theft occurs.
摘要翻译：一种防止包括使用无线个域网（PAN）或无线局域网（LAN）的移动设备的监视目标的丢失/窃取的方法和系统，所述无线局域网（LAN）可以从包括在监视目标中的移动设备经由网关，通过使用用于监视目标的移动设备信息生成的监视目标的位置信息，由移动设备的传感器收集的移动设备信息以及在移动设备和固定设备之间传送的信号信息可以确定是否通过比较监视目标信息和许可标准，可能会发生丢失或盗窃，并且可以在发生丢失或盗窃时提供包括监视目标位置信息在内的警报信息。

3. 发明申请

US20120144510A1 TREATMENT OF ASTROCYTES-TUMOR CELLS INHIBITORS OF ENDOTHELIN RECEPTORS 有权
标题翻译：内皮素受体的ASTROCYTES-TUMOR细胞抑制剂的治疗
公开(公告)号：US20120144510A1
公开(公告)日：2012-06-07
申请号：US13390072
申请日：2010-08-09
申请人： Isaiah J. Fidler , Sun-Jin Kim
发明人： Isaiah J. Fidler , Sun-Jin Kim
IPC分类号： A61K31/506 , C40B30/04 , C12N5/09 , A61P35/04 , A01K67/027
CPC分类号： A61K31/513 , A01K67/027 , A01K2227/105 , A01K2267/0331 , A61K31/337 , A61K31/4188 , A61K31/495 , A61K31/506 , A61K45/06 , A61N5/1084 , C12N5/0622 , C12N5/0693 , C12N2502/08 , C12N2502/30 , G01N33/5008 , A61K2300/00
摘要： The disclosure relates to an endothelin receptor antagonist for use in the prevention or treatment of brain metastases in combination with a cytotoxic chemotherapy agent, radiotherapy or both. The endothelin receptor antagonist may for example be bosentan, macitentan or a mixture of bosentan and macitentan.
摘要翻译：本公开涉及用于预防或治疗脑转移的内皮素受体拮抗剂，其与细胞毒性化疗剂，放射疗法或两者结合使用。内皮缩血管肽受体拮抗剂可以是例如波生坦，微生物素或波生坦和麦可坦的混合物。

4. 发明申请

US20080063727A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid 审中-公开
标题翻译：包封在透明质酸微粒中的药物的缓释组合物
公开(公告)号：US20080063727A1
公开(公告)日：2008-03-13
申请号：US11979148
申请日：2007-10-31
申请人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
发明人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
IPC分类号： A61K38/22 , A61K38/02 , A61K38/27 , A61K38/30 , A61K9/14 , A61K38/49 , A61K38/28 , A61K38/21
CPC分类号： A61K9/14 , A61K9/0024 , A61K9/1652 , A61K38/00
摘要： A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要翻译：一种基本上由具有高分子量的透明质酸微粒或其无机盐组成的缓释药物组合物和包在所述微粒中的蛋白质或肽药物，其中所述微粒的平均尺寸为0.1-40μm。

5. 发明申请

US20050100605A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid 审中-公开
标题翻译：包封在透明质酸微粒中的药物的缓释组合物
公开(公告)号：US20050100605A1
公开(公告)日：2005-05-12
申请号：US11013354
申请日：2004-12-17
申请人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
发明人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
IPC分类号： A61K9/16 , A61K38/48 , A61K39/395 , A61K9/22 , A61K9/14 , A61K38/19 , A61K38/22 , A61K38/21
CPC分类号： A61K9/1652 , Y10S514/951
摘要： A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要翻译：一种基本上由具有高分子量的透明质酸微粒或其无机盐组成的缓释药物组合物和包在所述微粒中的蛋白质或肽药物，其中所述微粒的平均尺寸为0.1-40μm。

6. 发明申请

US20110020458A1 SUSTAINED-RELEASE COMPOSITION OF DRUGS ENCAPSULATED IN MICROPARTICLES OF HYALURONIC ACID 审中-公开
标题翻译：持续释放组合物中加入羟丙酸微量元素的药物
公开(公告)号：US20110020458A1
公开(公告)日：2011-01-27
申请号：US12893203
申请日：2010-09-29
申请人： Myung-Jin KIM , Sun-Jin Kim , Oh-Ryong Kwon
发明人： Myung-Jin KIM , Sun-Jin Kim , Oh-Ryong Kwon
IPC分类号： A61K9/14 , A61K38/02 , A61K38/27 , A61K38/25 , A61K38/19 , A61K38/18 , A61K38/21 , A61K38/28 , A61K38/22 , A61K39/395 , A61K38/20 , A61K38/30 , A61K38/49 , A61K9/12
CPC分类号： A61K9/14 , A61K9/0024 , A61K9/1652 , A61K38/00
摘要： A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要翻译：一种基本上由具有高分子量的透明质酸微粒或其无机盐组成的缓释药物组合物和包裹在所述微粒中的蛋白质或肽药物，其中所述微粒的平均尺寸为0.1-40μm。

7. 发明授权

US07276251B2 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid 有权
标题翻译：包封在透明质酸微粒中的药物的缓释组合物
公开(公告)号：US07276251B2
公开(公告)日：2007-10-02
申请号：US10205954
申请日：2002-07-26
申请人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
发明人： Myung-Jin Kim , Sun-Jin Kim , Oh-Ryong Kwon
IPC分类号： A61K9/19 , A61K9/22
CPC分类号： A61K9/1652 , Y10S514/951
摘要： A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm.
摘要翻译：一种基本上由具有高分子量的透明质酸微粒或其无机盐组成的缓释药物组合物和包在所述微粒中的蛋白质或肽药物，其中所述微粒的平均尺寸为0.1-40μm。

8. 发明申请

US20140242204A1 PHARMACEUTICAL COMPOSITION INCLUDING C3G OR MULBERRY EXTRACTS CONTAINING C3G FOR PREVENTING OR TREATING DIABETIC IMPOTENCE 有权
标题翻译：药物组合物，包括含有C3G或用于预防或治疗糖尿病的C3G或MULBERRY提取物
公开(公告)号：US20140242204A1
公开(公告)日：2014-08-28
申请号：US14342004
申请日：2012-03-22
申请人： Sae-Woong Kim , Myung-Hoon Chun , In-Beom Kim , U-Syn Ha , Sun-Jin Kim , Woong-Jin Bae , Yong-Sun Choi
发明人： Sae-Woong Kim , Myung-Hoon Chun , In-Beom Kim , U-Syn Ha , Sun-Jin Kim , Woong-Jin Bae , Yong-Sun Choi
IPC分类号： A61K31/7048 , A61K36/605
CPC分类号： A61K31/7048 , A61K36/605
摘要： The present invention relates to the ameliorating effects of C3G (Cyanidin-3-O-β-d-glucopyranoside) on diabetic erectile dysfunction. In particular, the present invention relates to a pharmaceutical composition and food composition for preventing or treating diabetic erectile dysfunction comprising C3G. In addition, the present invention relates to a pharmaceutical composition and food composition for preventing or treating diabetic erectile dysfunction comprising extract of mulberry containing C3G.
摘要翻译：本发明涉及C3G（氰基-3-O-和b-D-吡喃葡萄糖苷）对糖尿病勃起功能障碍的改善作用。特别地，本发明涉及用于预防或治疗包含C3G的糖尿病勃起功能障碍的药物组合物和食品组合物。此外，本发明涉及包含含有含有C3G的桑叶提取物的糖尿病性勃起功能障碍的药物组合物和食品组合物。

9. 发明授权

US07232784B2 Metal oxide-containing kenyaite catalyst, method for preparing the same, and method for preparing ε-caprolactam using the same 失效
标题翻译：含有金属氧化物的肯尼亚特催化剂，其制备方法以及使用该催化剂制备ε-己内酰胺的方法
公开(公告)号：US07232784B2
公开(公告)日：2007-06-19
申请号：US11022250
申请日：2004-12-23
申请人： Sun-Jin Kim , Oh-Shim Joo , Kwang-Deog Jung , Min-Jo Park
发明人： Sun-Jin Kim , Oh-Shim Joo , Kwang-Deog Jung , Min-Jo Park
IPC分类号： B01J23/00 , C07D201/04
CPC分类号： B01J29/049 , B01J21/16
摘要： Disclosed are a kenyaite catalyst containing a metal oxide between layers of a layered silicate having kenyaite structure, a method for preparing the same, and a method for preparing ε-caprolactam from cyclohexanone oxime by applying the catalyst to gas phase Beckmann rearrangement.
摘要翻译：公开了在具有肯尼亚结构的层状硅酸盐的层之间含有金属氧化物的肯尼亚特催化剂，其制备方法，以及通过将催化剂用于气相贝克曼重排而由环己酮肟制备ε-己内酰胺的方法。

10. 发明授权

US07785625B2 Lipophilic-coated microparticle containing a protein drug and formulation comprising same 有权
标题翻译：含有蛋白质药物的亲油性包衣微粒和包含其的制剂
公开(公告)号：US07785625B2
公开(公告)日：2010-08-31
申请号：US11024362
申请日：2004-12-28
申请人： Myung-Jin Kim , Sun-Jin Kim , Kyu-Chan Kwon , Joon Kim
发明人： Myung-Jin Kim , Sun-Jin Kim , Kyu-Chan Kwon , Joon Kim
IPC分类号： A61K9/19 , A61K9/22
CPC分类号： A61K9/167 , A61K9/1617 , A61K9/1652 , C08L5/08 , C08L2666/02
摘要： A solid lipophilic microparticle having an average particle size ranging from 0.1 to 200 μm, comprising a lipophilic substance, hyaluronic acid or an inorganic salt thereof and an active ingredient selected from the group consisting of a protein or peptide drug, retains the full activity of the active ingredient, and when formulated in the form of an oil dispersion or oil-in-water emulsion, it releases in an in vivo environment the active ingredient in a controlled manner over a long period.
摘要翻译：平均粒度为0.1〜200μm的固体亲脂性微粒，其包含亲脂性物质，透明质酸或其无机盐，以及选自蛋白质或肽类药物的活性成分，保留了全部活性活性成分，当以油分散体或水包油乳剂的形式配制时，其在长时间内以有控制的方式在体内环境中释放活性成分。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式